Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6);Bovine Respiratory Syncytial

22 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

10000.0%

Death Rate

Active Ingredients

Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6);Bovine Respiratory Syncytial

Administration Routes

NasalSubcutaneous

Species Affected

Cattle 22

Most Affected Breeds

Mixed (Cattle) 20

Cattle (other) 1

Holstein-Friesian also known as Holstein 1

Most Reported Reactions

Death 22

Lack of efficacy - NOS 16

Necropsy performed 7

Lack of efficacy (bacteria) - NOS 3

Lack of efficacy (mycoplasma) - NOS 1

Extra dose(s) administered 1

Lack of efficacy (virus) - NOS 1

Anaphylactic-type reaction 1

Death by euthanasia 1

Injection site seroma 1

Injection site abscess 1

Third eyelid protrusion 1

Outcome Breakdown

Died

22 (48.9%)

Outcome Unknown

11 (24.4%)

Ongoing

8 (17.8%)

Euthanized

2 (4.4%)

Recovered with Sequela

1 (2.2%)

Recovered/Normal

1 (2.2%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.